Emcure Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE168P01015
  • NSEID: EMCURE
  • BSEID: 544210
INR
1,506.20
36.1 (2.46%)
BSENSE

Feb 03

BSE+NSE Vol: 1.37 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryEmcure Pharma VS Pharmaceuticals & Biotechnology
 
1D
2.46%
2.55%
1W
1.45%
2.19%
1M
5.26%
-2.28%
YTD
10.38%
-1.54%
1Y
20.68%
10.13%
3Y
%
44.1%
5Y
%
73.95%
10Y
%
249.47%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.2%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
13.59%
0%
13.59%
6 Months
10.41%
0.21%
10.62%
1 Year
20.68%
0.26%
20.94%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 3 per share ex-dividend date: Aug-14-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available